Celia H. Mitton

Oxford, ENG OX37LJ, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Phase I/IIa study to assess the safety, immunogenicity and efficacy of ChAdOx1-MVA vectored vaccines expressing a novel liver-stage malaria dual antigen LS2 by sporozoite challenge in malaria-naïve adults.

Phase I/IIa study to assess the safety, immunogenicity and efficacy of ChAdOx1-MVA vectored vaccines expressing a novel liver-stage malaria dual antigen LS2 by sporozoite challenge in malaria-naïve adults.

Journal: Wellcome open research

Published: March 19, 2026

Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infection.

Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infection.

Journal: Nature communications

Published: June 20, 2025

Early mucosal responses following a randomised controlled human inhaled infection with attenuated Mycobacterium bovis BCG.

Early mucosal responses following a randomised controlled human inhaled infection with attenuated Mycobacterium bovis BCG.

Journal: Nature communications

Published: August 01, 2024

A dose escalation study to evaluate the safety of an aerosol BCG infection in previously BCG-vaccinated healthy human UK adults.

A dose escalation study to evaluate the safety of an aerosol BCG infection in previously BCG-vaccinated healthy human UK adults.

Journal: Frontiers in immunology

Published: May 03, 2024

Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: Safety and parasite growth dynamics.

Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: Safety and parasite growth dynamics.

Journal: Frontiers in immunology

Published: July 01, 2022

Controlled human malaria infection with a clone of Plasmodium vivax with high-quality genome assembly.

Controlled human malaria infection with a clone of Plasmodium vivax with high-quality genome assembly.

Journal: JCI insight

Published: October 05, 2021

Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination.

Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination.

Journal: Med (New York, N.Y.)

Published: July 05, 2021

Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex Subspecies.

Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex Subspecies.

Journal: Vaccines

Published: February 10, 2021

Safety and immunogenicity of novel 5T4 viral vectored vaccination regimens in early stage prostate cancer: a phase I clinical trial.

Safety and immunogenicity of novel 5T4 viral vectored vaccination regimens in early stage prostate cancer: a phase I clinical trial.

Journal: Journal for immunotherapy of cancer

Published: May 26, 2020

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine.

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine.

Journal: Vaccines

Published: March 11, 2019

Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line.

Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line.

Journal: Vaccines

Published: January 22, 2019

Showing 1-11 of 11

Last Updated: 09/26/2026